Transactions
1
Insider / Medtronic plc
Groetelaars John P
Director at Medtronic plc
- Company
- Medtronic plc
- Ticker
- MDT
- First filing on record
- April 29, 2026
- Latest trade on record
- April 27, 2026
- SEC filings
- EDGAR ↗
Groetelaars John P, Director at Medtronic plc, has disclosed 1 transaction in MDT since April 29, 2026: 0 purchases (0 open-market buys) and 0 sales, worth about $0 at the reported prices. The latest was filed April 29, 2026, 2 days after the trade.
Open-market buys
0
Sales
0
Avg. disclosure lag
2.0d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months Groetelaars John P reported 1 transaction that was neither a purchase nor a sale, such as stock awards, option exercises or shares withheld for tax.
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| A | Grant or award | 1 | 1,444 | — |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 1 | 0 | 0 |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| MDT | Other A | April 27, 2026 | April 29, 2026 | 2d | 1,444 | — | — | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| April 29, 2026 | Form 4 | 0001580664-26-000002 | 1 | published | EDGAR ↗ |
Other insiders at Medtronic plc
- KIIL HARRY SKIP EVP & President Cardiovascular 22 rows
- ARNOLD CRAIG Director 17 rows
- Blomquist Denise L. Chief Accounting Officer 13 rows
- DONNELLY SCOTT C Director 11 rows
- Marinaro Michael EVP, Pres MedSurg and Americas 11 rows
- Martha Geoffrey Chairman and CEO 11 rows
- Walter Matthew R. SVP, Chief HR Officer 9 rows
- Fonseca Lidia Director 7 rows
- Smith Gregory L EVP Global Ops & Supply Chain 7 rows
- Jellison William R Director 6 rows
Everyone on file, with contracts and lobbying under the company's name: Medtronic plc.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 1 | 1 | April 29, 2026 | April 29, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.